Navigation Links
BIOCRATES Life Sciences to Launch Waters Xevo® TQ MS Editions for Two of its Well-established Research Kit Products, AbsoluteIDQ® p180 and p150
Date:5/21/2012

VIENNA, May 21, 2012 /PRNewswire/ --

Austrian BIOCRATES Life Sciences AG, prime developer of state-of-the-art metabolite biomarker panels, is about to launch new editions of two of its well-established research kit products -AbsoluteIDQ® p180 and p150. Originally developed for use with the AB Sciex mass spectrometers, both kits are now available for Waters Xevo® TQ MS systems,  greatly increasing sample throughput and accelerating up analytical processes.

AbsoluteIDQ® p180 Kit-Waters Xevo® TQ MS edition
Now also running on the ACQUITY UPLC® system by Waters, the new edition of the AbsoluteIDQ  p180 Kit speeds up your research, requiring only 16 hours of measurement time compared with 32 hours for conventional high performance liquid chromatography (HPLC). The Waters UPLC® technology was created especially for scientists who seek a reliable technology that simultaneously improves laboratory productivity, efficiency, and throughput.

Quantifying more than 180 metabolites from key metabolic pathways, the AbsoluteIDQ p180 Kit delivers the widest range of metabolomic information available from a single targeted assay. Analyzed metabolite classes include acylcarnitines, amino acids and biogenic amines, hexose, and sphingo- and glycerophospholipids.

AbsoluteIDQ® p150 Kit-Waters Xevo® TQ MS edition
Also now available for Waters Xevo TQ mass spectrometers is the AbsoluteIDQ p150 Kit, which identifies and quantifies 158 metabolites from 4 compound classes using a FIA-MS/MS method.

Both kits feature the proprietary MetIDQ™ software for the automated calculation of metabolite concentrations, require only small sample volumes of 10 µL, and are suitable for use with a wide range of biological samples.

About BIOCRATES
BIOCRATES Life Sciences AG is a leading biotechnology company focused on biomarker discovery and the development of  MS-based standardized metabolomics kits as well as in vitro diagnostics (IVDs). Please visit us at http://www.biocrates.com.

For questions: Michael Leitner, Public Health PR
Tel.: +43-1-602-05-30-92, e-mail: michael.leitner@publichealth.at


'/>"/>
SOURCE Biocrates Life Sciences AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
2. Egalet to Present at Life Sciences Europe Conference
3. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
4. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
5. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
10. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
11. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):